Peripheral blood markers predict immunotherapeutic efficacy in patients with advanced non-small cell lung cancer: A multicenter study

This study aims to investigate the prognostic impact of peripheral blood markers in patients with advanced non-small cell lung cancer (NSCLC) undergoing immunotherapy. In the current multicenter study, 157 advanced NSCLC cases treated by immunotherapy at three institutions were included. Biochemical...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shuai, Zhao, Liuyuan, Zhou, Guohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630578/
https://www.ncbi.nlm.nih.gov/pubmed/36338995
http://dx.doi.org/10.3389/fgene.2022.1016085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630578/
https://www.ncbi.nlm.nih.gov/pubmed/36338995
http://dx.doi.org/10.3389/fgene.2022.1016085

Ejemplares similares